This study was conducted to determine sex/gender differences in smoke exposure and to quantify the role of potential predictors including puffing behaviors, nicotine dependence, and non-nicotinic factors.
Methods:
The Pennsylvania Adult Smoking Study (PASS) of 332 adult cigarette smokers utilized portable handheld topography devices to capture the smokers' profiles in a naturalistic environment. Sex/gender differences in salivary biomarkers were modeled using ANCOVA to account for measures of dependence (Fagerstrom Test for Nicotine Dependence, nicotine metabolite ratio [3-hydroxycotinine/cotinine]), and nondependence covariates including anthropomorphic factors and stress. The Blinder-Oaxaca method was used to decompose the sex/gender differences in nicotine uptake due to covariates.
Results:
Men had significantly higher cotinine levels (313.5 ng/mL vs. 255.8 ng/mL, p < 0.01), cotinine +3-hydroxycotinine levels, (0.0787 mol/L vs. 0.0675 mol/L, p = 0.01), puff volumes (52.95 mL vs. 44.77 mL, p < 0.01), and a lower nicotine metabolite ratio (0.396 vs. 0.475, p = 0.01) than women. The mean Fagerström Test for Nicotine Dependence score did not differ between men and women (p = 0.24). Women had a higher mean Hooked on Tobacco Checklist score than men (7.64 vs. 6.87, p < 0.01). In multivariate analysis, nicotine metabolite levels were not significantly different by sex. Decomposition results show that ten predictors can explain 83% of the sex/gender differences in cotinine uptake. Height was the greatest contributor to these differences, followed by average puff volume.
Conclusion and Impact:
The higher levels of nicotine metabolites in men, compared to women, can be explained by height, weight, puff volume, and nicotine metabolism.
Get full access to this article
View all access options for this article.
References
1.
WetherillRR, JagannathanK, ShinJ, FranklinTR. Sex differences in resting state neural networks of nicotine-dependent cigarette smokers. Addict Behav, 2014; 39:789–792.
2.
MendrekA, Dinh-WilliamsL, BourqueJ, PotvinS. Sex differences and menstrual cycle phase-dependent modulation of craving for cigarette: An FMRI pilot study. Psychiatry J, 2014; 2014:723632.
3.
BohadanaA, NilssonF, RasmussenT, MartinetY. Gender differences in quit rates following smoking cessation with combination nicotine therapy: Influence of baseline smoking behavior. Nicotine Tob Res, 2003; 5:111–116.
4.
EissenbergT, AdamsC, RigginsEC3rd, LiknessM. Smokers' sex and the effects of tobacco cigarettes: Subject-rated and physiological measures. Nicotine Tob Res, 1999; 1:317–324.
5.
PotterAS. Smoking cessation in men and women. Am J Psychiatry, 2014; 171:1148–1150.
6.
SmithPH, KaszaKA, HylandA, et al.Gender differences in medication use and cigarette smoking cessation: Results from the International Tobacco Control Four Country Survey. Nicotine Tob Res, 2015; 17:463–472.
7.
ScharfD, ShiffmanS. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction, 2004; 99:1462–1469.
8.
Cepeda-BenitoA, ReynosoJT, ErathS. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. J Consult Clin Psychol, 2004; 72:712–722.
9.
BenowitzNL, HatsukamiD. Gender differences in the pharmacology of nicotine addiction. Addict Biol, 1998; 3:383–404.
10.
FieldM, DukaT. Cue reactivity in smokers: The effects of perceived cigarette availability and gender. Pharmacol Biochem Behav, 2004; 78:647–652.
11.
SaladinME, GrayKM, CarpenterMJ, LaRoweSD, DeSantisSM, UpadhyayaHP. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict, 2012; 21:210–220.
12.
McClernonFJ, KozinkRV, RoseJE. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology, 2008; 33:2148–2157.
13.
FergusonSG, FrandsenM, DunbarMS, ShiffmanS. Gender and stimulus control of smoking behavior. Nicotine Tob Res, 2015; 17:431–437.
14.
PomerleauCS, KurthCL. Willingness of female smokers to tolerate postcessation weight gain. J Subst Abuse, 1996; 8:371–378.
15.
Abuse NIoD. Are There Gender Differences in Tobacco Smoking?July2012. Available at: www.drugabuse.gov/publications/research-reports/tobacco/are-there-gender-differences-in-tobacco-smoking Accessed August8, 2017.
16.
BranstetterSA, BlosnichJ, DinoG, NolanJ, HornK. Gender differences in cigarette smoking, social correlates and cessation among adolescents. Addict Behav, 2012; 37:739–742.
17.
BerlinI, SingletonEG, PedarriosseAM, et al.The Modified Reasons for Smoking Scale: Factorial structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction, 2003; 98:1575–1583.
18.
HuangB, InagakiK, YoshiiC, et al.Social nicotine dependence in Australian dental undergraduate students. Int Dent J, 2011; 61:152–156.
19.
BucknerJD, VinciC. Smoking and social anxiety: The roles of gender and smoking motives. Addict Behav, 2013; 38:2388–2391.
20.
WatsonNL, VanderVeenJW, CohenLM, DeMarreeKG, MorrellHE. Examining the interrelationships between social anxiety, smoking to cope, and cigarette craving. Addict Behav, 2012; 37:986–989.
21.
ShiffmanS, PatonSM. Individual differences in smoking: Gender and nicotine addiction. Nicotine Tob Res, 1999; 1Suppl 2:S153–S157; discussion S165–S156.
22.
TorresOV, O'DellLE. Stress is a principal factor that promotes tobacco use in females. Prog Neuropsychopharmacol Biol Psychiatry, 2016; 65:260–268.
23.
HerschJ. Gender, income levels, and the demand for cigarettes. J Risk Uncertainty, 2000; 263:263–282.
24.
CosgroveKP, WangS, KimSJ, et al.Sex differences in the brain's dopamine signature of cigarette smoking. J Neurosci, 2014; 34:16851–16855.
25.
MelikianAA, DjordjevicMV, HoseyJ, et al.Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res, 2007; 9:377–387.
EtterJF, Vu DucT, PernegerTV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol, 2000; 151:251–258.
28.
GanWQ, CohenSB, ManSF, SinDD. Sex-related differences in serum cotinine concentrations in daily cigarette smokers. Nicotine Tob Res, 2008; 10:1293–1300.
29.
AssafAR, ParkerD, LapaneKL, McKenneyJL, CarletonRA. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Womens Health (Larchmt), 2002; 11:899–906.
30.
ZemanMV, HirakiL, SellersEM. Gender differences in tobacco smoking: Higher relative exposure to smoke than nicotine in women. J Womens Health Gend Based Med, 2002; 11:147–153.
31.
MuscatJE, DjordjevicMV, ColosimoS, StellmanSD, RichieJPJr.Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer, 2005; 103:1420–1426.
32.
WagenknechtLE, CutterGR, HaleyNJ, et al.Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health, 1990; 80:1053–1056.
33.
KrebsNM, ChenA, ZhuJ, et al.Comparison of puff volume with cigarettes per day in predicting nicotine uptake among daily smokers. Am J Epidemiol, 2016; 184:48–57.
34.
StrasserAA, PickworthWB, PattersonF, LermanC. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev, 2004; 13(11 Pt 1):1800–1804.
35.
HoferI, NilR, BattigK. Nicotine yield as determinant of smoke exposure indicators and puffing behavior. Pharmacol Biochem Behav, 1991; 40:139–149.
36.
BridgesRB, CombsJG, HumbleJW, TurbekJA, RehmSR, HaleyNJ. Puffing topography as a determinant of smoke exposure. Pharmacol Biochem Behav, 1990; 37:29–39.
37.
LeeEM, MalsonJL, WatersAJ, MoolchanET, PickworthWB. Smoking topography: Reliability and validity in dependent smokers. Nicotine Tob Res, 2003; 5:673–679.
38.
WilliamsJM, GandhiKK, LuSE, SteinbergML, BenowitzNL. Nicotine intake and smoking topography in smokers with bipolar disorder. Bipolar Disord, 2012; 14:618–627.
39.
Women & Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (RO1). Department of Health and Human Services website. Accessed April28, 2017.
40.
PogunS, YararbasG. Sex differences in nicotine action. Handb Exp Pharmacol, 2009:261–291.
41.
SmithPH, BessetteAJ, WeinbergerAH, ShefferCE, McKeeSA. Sex/gender differences in smoking cessation: A review. Prev Med, 2016; 92:135–140.
42.
CohenS, KamarckT, MermelsteinR. A global measure of perceived stress. J Health Soc Behav, 1983; 24:385–396.
43.
KesslerRC, AndrewsG, ColpeLJ, et al.Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med, 2002; 32:959–976.
44.
HamiltonCM, StraderLC, PrattJG, et al.The PhenX Toolkit: Get the most from your measures. Am J Epidemiol, 2011; 174:253–260.
45.
HarrisPA, TaylorR, ThielkeR, PayneJ, GonzalezN, CondeJG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 2009; 42:377–381.
46.
ChenG, GiambroneNEJr., DluzenDF, et al.Glucuronidation genotypes and nicotine metabolic phenotypes: Importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Res, 2010; 70:7543–7552.
47.
KrebsNM, ChenA, ZhuJ, et al.Comparison of puff volume with cigarettes per day in predicting nicotine uptake among daily smokers. Am J Epidemiol, 2016; 184:48–57.
48.
ZhuAZ, RennerCC, HatsukamiDK, et al.The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: The influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev, 2013; 22:708–718.
49.
CaraballoRS, HolidayDB, StellmanSD, et al.Comparison of serum cotinine concentration within and across smokers of menthol and nonmenthol cigarette brands among non-Hispanic black and non-Hispanic white U.S. adult smokers, 2001–2006. Cancer Epidemiol Biomarkers Prev, 2011; 20:1329–1340.
50.
BranstetterSA, MuscatJE. Time to first cigarette and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels in adult smokers; National Health and Nutrition Examination Survey (NHANES), 2007–2010. Cancer Epidemiol Biomarkers Prev, 2013; 22:615–622.
51.
JannB. The Blinder-Oaxaca decomposition for linear regression models. Stata J, 2008; 8:453–479.
52.
OaxacaRL. Male-female wage differentials in urban labor markets. Int Econ Rev, 1973; 14:693–709.
53.
BauerT, GöhlmannS, SinningM. Gender differences in smoking behavior. Health Econ, 2007; 16:895–909.
54.
OaxacaRL. Another look at tests of equality between sets of coefficients in 2 linear regressions. Am Econ, 1974; 18:23–32.
55.
BlinderAS. Wage discrimination—reduced form and structural estimates. J Hum Resour, 1973; 8:436–455.
56.
HeathertonTF, KozlowskiLT, FreckerRC, FagerstromKO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br J Addict, 1991; 86:1119–1127.
57.
PayneTJ, SmithPO, McCrackenLM, McSherryWC, AntonyMM. Assessing nicotine dependence: A comparison of the Fagerstrom Tolerance Questionnaire (FTQ) with the Fagerstrom Test for Nicotine Dependence (FTND) in a clinical sample. Addict Behav, 1994; 19:307–317.
58.
FagerstromKO, KunzeM, SchoberbergerR, et al.Nicotine dependence versus smoking prevalence: Comparisons among countries and categories of smokers. Tob Control, 1996; 5:52–56.
59.
JamalA, HomaDM, O'ConnorE, et al.Current cigarette smoking among adults - United States, 2005–2014. MMWR Morb Mortal Wkly Rep, 2015; 64:1233–1240.
60.
DiFranzaJR, WellmanRJ, SavageauJA, BecciaA, UrsprungWW, McMillenR. What aspect of dependence does the fagerstrom test for nicotine dependence measure?. ISRN Addict, 2013; 2013:906276.
61.
RichardsonL, GravesL. Rethinking an assessment of nicotine dependecne: A sex, gender and diversity analysis of the Fagerstrom Test for Nicotine Dependence. J Smoking Cessation, 2007; 2:59–67.
62.
AugustsonEM, BarzaniD, RuttenLJ, MarcusS. Gender differences among hardcore smokers: An analysis of the tobacco use supplement of the current population survey. J Womens Health (Larchmt), 2008; 17:1167–1173.
63.
WellmanRJ, SavageauJA, GodiwalaS, et al.A comparison of the Hooked on Nicotine Checklist and the Fagerstrom Test for Nicotine Dependence in adult smokers. Nicotine Tob Res, 2006; 8:575–580.
64.
MuscatJE, StellmanSD, CaraballoRS, RichieJPJr.Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev, 2009; 18:3415–3420.
65.
AllenAM, ScheuermannTS, NollenN, HatsukamiD, AhluwaliaJS. Gender differences in smoking behavior and dependence motives among daily and nondaily smokers. Nicotine Tob Res, 2016; 18:1408–1413.
66.
EmmonsKM, ThompsonB, McLerranD, et al.The relationship between organizational characteristics and the adoption of workplace smoking policies. Health Educ Behav, 2000; 27:483–501.
67.
JonesRL, NzekwuMM. The effects of body mass index on lung volumes. Chest, 2006; 130:827–833.
68.
KieferEM, HankinsonJL, BarrRG. Similar relation of age and height to lung function among Whites, African Americans, and Hispanics. Am J Epidemiol, 2011; 173:376–387.
69.
IstvanJA, NidesMA, BuistAS, GreeneP, VoelkerH. Salivary cotinine, frequency of cigarette smoking, and body mass index: Findings at baseline in the Lung Health Study. Am J Epidemiol, 1994; 139:628–636.
MuscatJE, RichieJPJr., StellmanSD. Mentholated cigarettes and smoking habits in whites and blacks. Tob Control, 2002; 11:368–371.
72.
MwenifumboJC, SellersEM, TyndaleRF. Nicotine metabolism and CYP2A6 activity in a population of black African descent: Impact of gender and light smoking. Drug Alcohol Depend, 2007; 89:24–33.
73.
WidomeR, JosephAM, HammettP, et al.Associations between smoking behaviors and financial stress among low-income smokers. Prev Med Rep, 2015; 2:911–915.
74.
Connor GorberS, TremblayM, MoherD, GorberB. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: A systematic review. Obes Rev, 2007; 8:307–326.
75.
PerkinsKA, EpsteinLH, SextonJE, StillerRL, JacobRG. Effects of dose, gender, and level of physical activity on acute metabolic response to nicotine. Pharmacol Biochem Behav, 1991; 40:203–208.
76.
BattigK, BuzziR, NilR. Smoke yield of cigarettes and puffing behavior in men and women. Psychopharmacology (Berl), 1982; 76:139–148.
77.
BenowitzNL, Lessov-SchlaggarCN, SwanGE, JacobP3rd. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther, 2006; 79:480–488.
78.
SchnollRA, GeorgeTP, HawkL, CinciripiniP, WileytoP, TyndaleRF. The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology (Berl), 2014; 231:2515–2523.
